Patient Buzz: The Mind-Skin Connection | The Expert Weighs In
Stylecaster recently posted an online article about psychodermatology. How do the mind and skin influence each other? What do we now know and what questions are still unanswered? How can dermatology clinicians best counsel their patients when the mind-skin connection is at work?
For expert advice, I reached out to Steven Daveluy, MD, FAAD, associate professor and program director at Wayne St …
Stylecaster recently posted an online article about psychodermatology. How do the mind and skin influence each other? What do we now know and what questions are still unanswered? How can dermatology clinicians best counsel their patients when the mind-skin connection is at work?
For expert advice, I reached out to Steven Daveluy, MD, FAAD, associate professor and program director at Wayne St … Continue reading "Patient Buzz: The Mind-Skin Connection | The Expert Weighs In"
Bimekizumab (Bimzelx®) is a new injectable medication FDA approved for plaque psoriasis. It is the first and only FDA approved IL-17A and IL-17F inhibitor for this disease, but is also being used as an off-label option for other conditions including psoriatic arthritis and hidradenitis suppurativa. This Therapeutic Cheat Sheet will focus on the on and off label uses of bimekizumab.
Bimekizuma …
Media attention about oral minoxidil has impacted access to the hair loss drug in the Washington, D.C. area, according to a study published in the January issue of the Journal of Drugs in Dermatology. Researchers found shortages of the drug in D.C.-area pharmacies more than a year after an article about the treatment appeared in The New York Times.
To find out more about oral minoxidil access, …
A 34-year-old man with no past medical conditions presents with lesions as shown. Of the following, what is the most likely causative agent?
A. Aspergillus flavus
B. Group A beta-hemolytic streptococci
C. Pseudomonas aeruginosa
D. Klebsiella
E. Proteus
To find out the correct answer and read the explanation, click here. …
Pretibial myxedema (PTM) is a rare complication of Graves' disease. It is characterized by non-pitting edema with hyperpigmented hyperkeratotic papules and plaques on bilateral lower legs. Effective treatments for patients with PTM are lacking. The etiology of PTM is unknown; however, it may be similar to the mechanism of thyroid-associated ophthalmopathy (TAO). Activated fibroblasts produce infla …